Literature DB >> 11479459

End points for cardiovascular drug trials in pediatric patients.

A R Sinaiko1, R M Lauer, S P Sanders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11479459     DOI： 10.1067/mhj.2001.117062

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  2 in total

1.  The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease.

Authors:  L Mahony; L A Sleeper; P A W Anderson; W M Gersony; B W McCrindle; L L Minich; J W Newburger; J P Saul; V L Vetter; G D Pearson
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

Review 2.  Long-term consequences of drugs on the paediatric cardiovascular system.

Authors:  Elizabeth Hausner; Monica L Fiszman; Joseph Hanig; Patricia Harlow; Gwen Zornberg; Solomon Sobel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.